Jefferies upgraded Supernus Pharmaceuticals (NASDAQ: SUPN) from Hold to Buy with a price target of $18.00, following a legal victory ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE